In most cases this reflects somatic, stabilizing mutations of CTNNB1 (β-catenin; 85–90%), which promote nuclear β-catenin accumulation and transcriptional activation; 10–15% of cases are instead related to germline APC mutations (FAP/Gardner syndrome). The gene discussed is CTNNB1; the disease is Gardner syndrome.